Inova Personalized Health Accelerator Accepting New Ventures for Accelerator Portfolio

FAIRFAX, Va., Sept. 5, 2017 /PRNewswire-USNewswire/-- The Inova Personalized Health Accelerator (IPHA) announced today it is officially accepting business plan applications from early stage healthcare technology firms with a focus on personalized health. Companies interested in consideration are encouraged to apply via the IPHA web site (

IPHA redefines the concept of early stage accelerators by helping its companies develop and execute plans of action that achieve significant milestones in value creation, risk mitigation and capital formation. The IPHA approach includes:

    --  A team of successful, entrepreneurial C-Suite executives that extend the
        existing management team to help the company execute its strategy and
        rapidly increase value.
    --  A $75,000 cash investment with C-Suite program services valued at
        $125,000 in return for a 10% equity position in the next funding round.
    --  A matching investment of up to $250,000 when the company meets all
        milestones and secures funding from a qualified investor(s) during the
        program, or up to 12 months after graduation from the IPHA program.
    --  Privileged access to the Inova Health System and extended family of
        health systems for potential product validation, early adoption, and
        future investment.

IPHA has a year-round, rolling application process, and will focus on a maximum of 6 companies at any time, in order to provide the individual attention that each company requires.

Companies that qualify are pre-series A and/or seed stage companies with working prototypes of their technology, who are seeking venture investment for product development and commercialization. The types of companies being sought include medical devices, diagnostics, digital health, sensor technologies, A.I./machine learning, genomics & precision medicine, and software/analytics. The technology for consideration may involve FDA 510(k) class I, II, or de novo regulatory pathways.

About Inova Personalized Health Accelerator
The Inova Personalized Health Accelerator is a unique program that provides C-suite coaches, customized plans, early stage capital, connections to strategic partners and later stage capital, and connections to customers for healthcare technology and services entrepreneurs. This bespoke approach to enhance med-tech entrepreneurs' efforts to accelerate new companies through the early stages of product design, capital formation and commercialization will serve as the foundation for a stronger healthcare ecosystem in the mid-Atlantic region. Additional program information is located at

About Inova
Inova is a global leader in personalized health, which leverages precision medicine to predict, prevent and treat disease, enabling individuals to live longer, healthier lives. At Inova, we serve more than 2 million people each year from throughout the Washington, DC, metro area and beyond.We are shaping the future of health through our integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes. Our commitment to health and wellness is further reflected in our sustainable practices. Inova is home to world-class researchers, expert medical specialists and renowned scientists, who are driving innovation to improve patient care, prevent disease and promote wellness. For more information, visit, or find Inova on Facebook, Twitter and LinkedIn.

Kelly Schlageter

View original content:

SOURCE Inova Health System